2010Journal of Nanchang UniversityRequires access

The Diagnosis and the Clinical Significance of Combined Detection of ANA,Anti-dsDNA,and anti-ENA Antibody in Systematic Lupus Erthematosus

Lian Jin-quan

Open publisher page 0 citations

Abstract

Objective To investigate the diagnostic significance of combined determination of the anti-nuclear antibody (ANA),anti-dsDNA,anti-extractable nuclear antigens(ENA) antibody in systematic lupus erythematosus.Methods Ninety-two SLE patients (SLE group) and 80 healthy people (control group)were examined and compared.ANA was tested by indirect immunofluorescence;anti-dsDNA was tested by immofiltration assay;anti-ENA antibody was tested by immunoblotting technique.Results ①The positive rate of ANA,anti-dsDNA and anti-ENA antibody in the SLE group patients were 89.1%,47.8% and 50.0% respectively;the positive rate of combined determination of ANA,anti-dsDNA and anti-ENA antibody was 94.5%.All the data in SLE group were higher than those in control group,which showed significant differences(P0.01).②The respective antibody positive rates of anti-ENA antibody in SLE group patients:the anti-Sm was 22.8%,the anti-SSA was 26.1%,the anti-SSB was 10.9%,the anti-U1RNP was 15.2%,the anti-rRNP was 9.7%,the anti-scl-70 was 1.1% and anti-Jo-1 was zero.③Of SLE group patients,40 were lupus nephtritis (LN group),52 were not lupus nephtritis(NLN group);the anti-dsDNA of the 30 patients in LN group was positive,whose rate was 75.0%;the 14 patients in NLN group are positive,whose rate is 26.9%,which shows significant differences(P0.01).Conclusion The determination of ANA,anti-dsDNA,and anti-ENA antibody may have important significance in diagnosis,differentiation,monitoring and treatment.The combined determination of ANA,anti-dsDNA and anti-ENA antibody could improve the determination percentage in SLE,which is complementary with each other.

About this research paper

What this paper is about

Objective To investigate the diagnostic significance of combined determination of the anti-nuclear antibody (ANA),anti-dsDNA,anti-extractable nuclear antigens(ENA) antibody in systematic lupus erythematosus.Methods Ninety-two SLE patients (SLE group) and 80 healthy people (control group)were examined and compared.ANA was tested by indirect immunofluorescence;anti-dsDNA was tested by immofiltration assay;anti-ENA antibody was tested by immunoblotting technique.Results ①The positive rate of ANA,anti-dsDNA and anti-ENA antibody in the SLE group patients were 89.1%,47.8% and 50.0% respectively;the positive rate of combined determination of ANA,anti-dsDNA and anti-ENA antibody was 94.5%.All the data in SLE group were higher than those in control group,which showed significant differences(P0.01).②The respective antibody positive rates of anti-ENA antibody in SLE group patients:the anti-Sm was 22.8%,the anti-SSA was 26.1%,the anti-SSB was 10.9%,the anti-U1RNP was 15.2%,the anti-rRNP was 9.7%,the anti-scl-70 was 1.1% and anti-Jo-1 was zero.③Of SLE group patients,40 were lupus nephtritis (LN group),52 were not lupus nephtritis(NLN group);the anti-dsDNA of the 30 patients in LN group was positive,whose rate was 75.0%;the 14 patients in NLN group are positive,whose rate is 26.9%,which shows significant differences(P0.01).Conclusion The determination of ANA,anti-dsDNA,and anti-ENA antibody may have important significance in diagnosis,differentiation,monitoring and treatment.The combined determination of ANA,anti-dsDNA and anti-ENA antibody could improve the determination percentage in SLE,which is complementary with each other.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the diagnostic significance of combined determination of the anti-nuclear antibody (ANA),anti-dsDNA,anti-extractable nuclear antigens(ENA) antibody in systematic lupus erythematosus.Methods Ninety-two SLE patients (SLE group) and 80 healthy people (control group)were examined and compared.ANA was tested by indirect immunofluorescence;anti-dsDNA was tested by immofiltration assay;anti-ENA antibody was tested by immunoblotting technique.Results ①The positive rate of ANA,anti-dsDNA and anti-ENA antibody in the SLE group patients were 89.1%,47.8% and 50.0% respectively;the positive rate of combined determination of ANA,anti-dsDNA and anti-ENA antibody was 94.5%.All the data in SLE group were higher than those in control group,which showed significant differences(P0.01).②The respective antibody positive rates of anti-ENA antibody in SLE group patients:the anti-Sm was 22.8%,the anti-SSA was 26.1%,the anti-SSB was 10.9%,the anti-U1RNP was 15.2%,the anti-rRNP was 9.7%,the anti-scl-70 was 1.1% and anti-Jo-1 was zero.③Of SLE group patients,40 were lupus nephtritis (LN group),52 were not lupus nephtritis(NLN group);the anti-dsDNA of the 30 patients in LN group was positive,whose rate was 75.0%;the 14 patients in NLN group are positive,whose rate is 26.9%,which shows significant differences(P0.01).Conclusion The determination of ANA,anti-dsDNA,and anti-ENA antibody may have important significance in diagnosis,differentiation,monitoring and treatment.The combined determination of ANA,anti-dsDNA and anti-ENA antibody could improve the determination percentage in SLE,which is complementary with each other.

Key concepts: Antibody, Anti-dsDNA antibodies, Extractable nuclear antigens, Systemic lupus erythematosus, Medicine, Internal medicine, Anti-nuclear antibody, Immunofluorescence

Related papers

Back to paper searchBrowse research topicsOriginal source
The Diagnosis and the Clinical Significance of Combined Detection of ANA,Anti-dsDNA,and anti-ENA Antibody in Systematic Lupus Erthematosus — Research Paper | ScholarLens